Rx Importation Is Unsustainable, Distributors Tell Task Force, Because Of Supply/Demand Imbalance
This article was originally published in The Pink Sheet Daily
Executive Summary
The limited availability of Canadian drugs will boost prices of drugs imported to the U.S. if importation were legalized, HDMA tells HHS’ Importation Task Force. High demand for lower-cost foreign drugs would require a controversial government allocation system, McKesson says.